-
Apellis Completes $47 Million Series D Financing
Read moreLOUISVILLE, Ky., Feb. 12, 2016 /PRNewswire/ — Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing,...
February 12, 201603